Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Yunnan Baiyao Group Co., (000538 CH)
Watchlist
56
Analysis
Health Care
•
China
Yunnan Baiyao Group Co., Ltd. manufactures and markets traditional Chinese medicines. The Company also operates in pharmaceutical wholesale and retail trading, empty capsules manufacturing, and hotel operation.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
14 Feb 2022 09:11
Zhangzhou Pientzehuang Pharmaceutical (600436.CH) - The Strength and the Concerns
We analyzed the business model of Pien Tze Huang, which is mainly due to its uniqueness and scarcity that build high moat. But it still has to...
Xinyao (Criss) Wang
Follow
233 Views
Share
bearish
•
Dong E E Jiaoco Ltd A
•
19 Jan 2022 09:01
Dong E E Jiao (000423.CH) - Could the New Chairman Turn Things Around?
The raw material (donkey skin) shortage is a big concern for Dong-E-E-Jiao's future development, together with low inventory turnover,fierce...
Xinyao (Criss) Wang
Follow
246 Views
Share
bearish
•
Thematic (Sector/Industry)
•
06 Jan 2022 08:44
The Concerns and Outlook About the Recent Rally in Traditional Chinese Medicine (TCM) Sector
The insight mainly analyzed the logic behind the recent rally in TCM sector, the policy impact, the concerns on limited resources, VBP,...
Xinyao (Criss) Wang
Follow
306 Views
Share
bearish
•
Guangzhou Baiyunshan Pharmaceutical Holdings
•
23 Dec 2021 09:10
Guangzhou Baiyunshan Pharmaceutical Holdings (874.HK) - Conservative About the Outlook
This insight analyzed Baiyunshan’s 2021Q3 performance, the core business segments, the comparison with peers, the concerns on business transition,...
Xinyao (Criss) Wang
Follow
503 Views
Share
bullish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
25 Oct 2021 08:54
Pientzehuang Pharmaceutical Co., Ltd. (600436.CH) 2021Q3 - Concerns Behind The "Double Top Secret"
The article mainly analyzed Zhangzhou Pien Tze Huang Pharmaceutical in terms of its 2021Q3 results and the concerns on medical efficacy, collection...
Xinyao (Criss) Wang
Follow
173 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x